RAY B Share Price Performance
SEK 0
-309.50 (-100.00%)
Price SEK 0
Fair ValueSEK 330.00
Share Pricen/a
Narrative Update • May 18
RaySearch Laboratories AB (publ) Stock Price
- 4 Narratives written by author
- 0 Comments on narratives written by author
- 19 Fair Values set on narratives written by author
RAY B Community Narratives
AN
Fair Value
·Fair Value SEK 330 39.3% undervalued intrinsic discount
Aging Population And AI Integration Will Expand Oncology Market
0users have liked this narrative
0users have commented on this narrative
9users have followed this narrative
AL
Fair Value
·Fair Value SEK 230.6 13.1% undervalued intrinsic discount
High-Tech Precision Play
0users have liked this narrative
0users have commented on this narrative
2users have followed this narrative
AN
Fair Value
·Fair Value SEK 290 30.9% undervalued intrinsic discount
Expansion Risks Beyond Radiotherapy Will Eventually Set Up A Stronger Long Term Platform
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
High-Tech Precision Play
1. The Narrative: The High Tech Precision Play The narrative for RaySearch is that of a highly specialized software leader in the oncology market.Read more
AL
SEK 230.6
13.1% undervalued intrinsic discount
Fair Value
Revenue
10% p.a.
Profit Margin
20%
Future PE
25x
Price in 2031
SEK 315.76
Aging Population And AI Integration Will Expand Oncology Market
RaySearch sells software that helps hospitals plan and manage cancer treatment, and it could benefit as cancer care demand grows and clinics upgrade old systems. New AI features and partnerships may bring in steadier, repeat business, but tighter rules and tougher competition could raise costs and make results more unpredictable.Read more
AN
SEK 330
39.3% undervalued intrinsic discount
Fair Value
Revenue
12.31% p.a.
Profit Margin
24.74%
Future PE
29.49x
Price in 2029
SEK 392.87
AI-Powered Radiotherapy Platforms Will Deepen Clinical Adoption And Strengthen Long-Term Earnings Potential
Catalysts About RaySearch Laboratories RaySearch Laboratories develops specialized software platforms that support planning, delivery and data driven optimization of cancer treatments across radiotherapy and related modalities. What are the underlying business or industry changes driving this perspective?Read more
AN
SEK 370
45.8% undervalued intrinsic discount
Fair Value
Revenue
15.44% p.a.
Profit Margin
23.39%
Future PE
31.67x
Price in 2029
SEK 446.8
Expansion Risks Beyond Radiotherapy Will Eventually Set Up A Stronger Long Term Platform
Catalysts About RaySearch Laboratories RaySearch Laboratories develops software platforms that support planning, delivery, coordination and analysis of cancer treatments across radiotherapy and other modalities. What are the underlying business or industry changes driving this perspective?Read more
AN
SEK 290
30.9% undervalued intrinsic discount
Fair Value
Revenue
16.84% p.a.
Profit Margin
23.28%
Future PE
25.05x
Price in 2029
SEK 350.53
Trending Discussion
Recently Updated Narratives
AL
High-Tech Precision Play
Fair Value: SEK 230.6 13.1% undervalued intrinsic discount
2 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
RAY B: Wartime Care And China Expansion Will Support Stronger Prospects
Fair Value: SEK 330 39.3% undervalued intrinsic discount
9 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
AI-Powered Radiotherapy Platforms Will Deepen Clinical Adoption And Strengthen Long-Term Earnings Potential
Fair Value: SEK 370 45.8% undervalued intrinsic discount
0 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
RaySearch Laboratories AB (publ) Key Details
Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
Aug 13, 2026
- 6.54
- 92.41%
- 17.20%
- 0%
About RAY B
- Founded
- 2000
- Employees
- 465
- CEO
- WebsiteView website
RaySearch Laboratories AB (publ), a medical technology company, provides software solutions for cancer treatment worldwide. It offers RayStation, a treatment planning system for cancer centers; RayCare, an oncology information system for clinics; RayIntelligence, cloud-based oncology analytics system that cancer centers can use to gather, structure and analyze data; and RayCommand, a treatment control system designed to link the treatment machine and the treatment planning and oncology information systems. It also provides µ-RayStation* (Micro-RayStation), a software platform for planning and evaluation in small animal irradiation research; RayPlan, a treatment planning system; DrugLog, which verifies the identity and concentration of compounded injectables before administered to a patient; RayMigrate, allows users to convert Pinnacle patient data to RayStation format and/or to DICOM format; Machine Learning; and Liver Ablation Solutions. The company was founded in 2000 and is headquartered in Stockholm, Sweden.
